Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ)
CNY 13.93
(-0.5%)
CNY 13.93
(-0.5%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.78 Billion CNY | 4.91% |
| 2022 | 4.49 Billion CNY | 9.91% |
| 2021 | 4.09 Billion CNY | 14.96% |
| 2020 | 3.55 Billion CNY | 9.5% |
| 2019 | 3.25 Billion CNY | 11.14% |
| 2018 | 2.92 Billion CNY | 13.59% |
| 2017 | 2.57 Billion CNY | 22.01% |
| 2016 | 2.11 Billion CNY | 17.78% |
| 2015 | 1.79 Billion CNY | 29.2% |
| 2014 | 1.38 Billion CNY | 24.08% |
| 2013 | 1.11 Billion CNY | 28.85% |
| 2012 | 867.41 Million CNY | 24.89% |
| 2011 | 694.51 Million CNY | 24.07% |
| 2010 | 559.77 Million CNY | 35.06% |
| 2009 | 414.46 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 1.3 Billion CNY | 6.3% |
| 2024 Q1 | 1.24 Billion CNY | -12.34% |
| 2024 Q2 | 1.26 Billion CNY | 1.83% |
| 2023 Q4 | 1.41 Billion CNY | 32.08% |
| 2023 Q1 | 1.13 Billion CNY | -2.94% |
| 2023 Q2 | 1.09 Billion CNY | -3.23% |
| 2023 FY | 4.71 Billion CNY | 4.91% |
| 2023 Q3 | 1.07 Billion CNY | -2.52% |
| 2022 Q1 | 1.1 Billion CNY | 3.87% |
| 2022 FY | 4.49 Billion CNY | 9.91% |
| 2022 Q4 | 1.17 Billion CNY | 5.5% |
| 2022 Q3 | 1.11 Billion CNY | 0.13% |
| 2022 Q2 | 1.1 Billion CNY | 0.14% |
| 2021 FY | 4.09 Billion CNY | 14.96% |
| 2021 Q4 | 1.06 Billion CNY | -1.71% |
| 2021 Q3 | 1.08 Billion CNY | 9.46% |
| 2021 Q2 | 990.61 Million CNY | 4.22% |
| 2021 Q1 | 950.54 Million CNY | -2.92% |
| 2020 Q3 | 914.87 Million CNY | 14.87% |
| 2020 FY | 3.55 Billion CNY | 9.5% |
| 2020 Q1 | 868.47 Million CNY | -3.0% |
| 2020 Q2 | 796.42 Million CNY | -8.3% |
| 2020 Q4 | 979.16 Million CNY | 7.03% |
| 2019 Q4 | 895.29 Million CNY | 8.98% |
| 2019 FY | 3.25 Billion CNY | 11.14% |
| 2019 Q3 | 821.51 Million CNY | 6.07% |
| 2019 Q2 | 774.53 Million CNY | 2.06% |
| 2019 Q1 | 758.93 Million CNY | -7.2% |
| 2018 Q2 | 678.86 Million CNY | -2.73% |
| 2018 Q1 | 697.88 Million CNY | -3.04% |
| 2018 FY | 2.92 Billion CNY | 13.59% |
| 2018 Q4 | 817.77 Million CNY | 12.03% |
| 2018 Q3 | 729.95 Million CNY | 7.53% |
| 2017 Q2 | 614.87 Million CNY | 6.37% |
| 2017 Q1 | 578.07 Million CNY | 1.11% |
| 2017 FY | 2.57 Billion CNY | 22.01% |
| 2017 Q4 | 719.77 Million CNY | 8.74% |
| 2017 Q3 | 661.91 Million CNY | 7.65% |
| 2016 Q1 | 519.15 Million CNY | 1.93% |
| 2016 Q2 | 497.23 Million CNY | -4.22% |
| 2016 FY | 2.11 Billion CNY | 17.78% |
| 2016 Q3 | 521.99 Million CNY | 4.98% |
| 2016 Q4 | 571.73 Million CNY | 9.53% |
| 2015 Q4 | 509.3 Million CNY | 8.43% |
| 2015 FY | 1.79 Billion CNY | 29.2% |
| 2015 Q2 | 437.41 Million CNY | 16.57% |
| 2015 Q1 | 375.22 Million CNY | 1.29% |
| 2015 Q3 | 469.69 Million CNY | 7.38% |
| 2014 Q2 | 349.7 Million CNY | 10.38% |
| 2014 FY | 1.38 Billion CNY | 24.08% |
| 2014 Q4 | 370.43 Million CNY | 5.9% |
| 2014 Q3 | 349.77 Million CNY | 0.02% |
| 2014 Q1 | 316.82 Million CNY | -0.29% |
| 2013 Q4 | 317.74 Million CNY | 11.91% |
| 2013 FY | 1.11 Billion CNY | 28.85% |
| 2013 Q2 | 272.13 Million CNY | 11.62% |
| 2013 Q3 | 283.93 Million CNY | 4.34% |
| 2013 Q1 | 243.81 Million CNY | 0.0% |
| 2012 FY | 867.41 Million CNY | 24.89% |
| 2011 FY | 694.51 Million CNY | 24.07% |
| 2010 FY | 559.77 Million CNY | 35.06% |
| 2009 FY | 414.46 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 1.36 Billion CNY | -251.019% |
| ZJAMP Group Co., Ltd. | 1.31 Billion CNY | -263.527% |
| Luyan Pharma Co.,Ltd. | 1.03 Billion CNY | -360.991% |
| Ji Yao Holding Group Co., Ltd. | 428.47 Million CNY | -1016.702% |